|
|
|
|
| LEADER |
01140nam a2200289 u 4500 |
| 001 |
10053731 |
| 003 |
upatras |
| 005 |
20220120140823.0 |
| 008 |
050513s2004 lu eng |
| 020 |
|
|
|a 9291681822
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a 615.1
|
| 245 |
1 |
0 |
|a Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs
|
| 260 |
|
|
|a Luxembourg
|b Office for Official Publications of the European Communities
|c 2004
|
| 300 |
|
|
|a 74 p.
|c 21 cm.
|
| 490 |
0 |
|
|a EMCDDA Risk Assessments
|v 7
|x 1725-4485
|
| 650 |
|
4 |
|a Ναρκωτικά
|9 7431
|
| 650 |
|
4 |
|a Τοξικολογία
|9 2079
|
| 650 |
|
4 |
|a Συνθετικά φάρμακα
|9 46140
|
| 650 |
|
4 |
|a Φαρμακολογία
|9 1400
|
| 760 |
0 |
|
|a EMCDDA Risk Assessments
|g 7
|x 1725-4485
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΚΕΤ
|h 615.1 REP
|m 078561
|p 025000115274
|t 1
|
| 942 |
|
|
|2 ddc
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_REP
|7 0
|9 47882
|a LISP
|b LISP
|c EDC
|d 2016-04-24
|i 078561
|l 0
|o 615.1 REP
|p 025000115274
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
| 998 |
|
|
|c ΗΛΙΟΠΟΥΛΟΥ
|d 2005-05
|
| 999 |
|
|
|c 30361
|d 30361
|
